CVS CVS HEALTH CORP revenue, earnings and financials

For the quarter ended June 30, 2026, CVS HEALTH CORP reported revenue of $106B (up 7.3% from a year earlier), net income of $2.98B and diluted EPS of $2.31; over the last four quarters revenue was $415B and net income $4.89B; for the fiscal year ended December 2025 revenue was $402B, up 7.8% on the year before.

CVS annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $402B, gross profit n/a, operating income $4.66B, net income $1.77B (margin 0.4%), EPS $1.39
• Fiscal year ended Dec 2024: revenue $373B, gross profit n/a, operating income $8.52B, net income $4.61B (margin 1.2%), EPS $3.66
• Fiscal year ended Dec 2023: revenue $358B, gross profit n/a, operating income $13.7B, net income $8.34B (margin 2.3%), EPS $6.47
• Fiscal year ended Dec 2022: revenue $322B, gross profit n/a, operating income $7.95B, net income $4.31B (margin 1.3%), EPS $3.26
• Fiscal year ended Dec 2021: revenue $292B, gross profit n/a, operating income $13.3B, net income $8.00B (margin 2.7%), EPS $6.02

CVS quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $106B (up 7.3% year over year), net income $2.98B, EPS $2.31
• Quarter ended Mar 31, 2026: revenue $100B (up 6.2% year over year), net income $2.94B, EPS $2.30
• Quarter ended Dec 31, 2025 (from the annual report): revenue $106B (up 8.2% year over year), net income $2.94B, EPS $2.31
• Quarter ended Sep 30, 2025: revenue $103B (up 7.8% year over year), net income −$3.98B, EPS −$3.13
• Quarter ended Jun 30, 2025: revenue $98.9B (up 8.4% year over year), net income $1.02B, EPS $0.80
• Quarter ended Mar 31, 2025: revenue $94.6B (up 7.0% year over year), net income $1.78B, EPS $1.41
• Quarter ended Dec 31, 2024 (from the annual report): revenue $97.7B (up 4.2% year over year), net income $1.64B, EPS $1.30
• Quarter ended Sep 30, 2024: revenue $95.4B (up 6.3% year over year), net income $87.0M, EPS $0.07
• Quarter ended Jun 30, 2024: revenue $91.2B (up 2.6% year over year), net income $1.77B, EPS $1.41
• Quarter ended Mar 31, 2024: revenue $88.4B (up 3.7% year over year), net income $1.11B, EPS $0.88
• Quarter ended Dec 31, 2023 (from the annual report): revenue $93.8B (up 11.9% year over year), net income $2.05B, EPS $1.59
• Quarter ended Sep 30, 2023: revenue $89.8B (up 10.6% year over year), net income $2.26B, EPS $1.75
• Quarter ended Jun 30, 2023: revenue $88.9B (up 10.3% year over year), net income $1.90B, EPS $1.48
• Quarter ended Mar 31, 2023: revenue $85.3B (up 11.0% year over year), net income $2.14B, EPS $1.65
• Quarter ended Dec 31, 2022 (from the annual report): revenue $83.8B (up 9.5% year over year), net income $2.33B, EPS $1.79
• Quarter ended Sep 30, 2022: revenue $81.2B (up 10.0% year over year), net income −$3.41B, EPS −$2.59
• Quarter ended Jun 30, 2022: revenue $80.6B (up 11.0% year over year), net income $3.03B, EPS $2.29
• Quarter ended Mar 31, 2022: revenue $76.8B (up 11.2% year over year), net income $2.35B, EPS $1.77
• Quarter ended Dec 31, 2021 (from the annual report): revenue $76.6B, net income $1.40B, EPS $1.04
• Quarter ended Sep 30, 2021: revenue $73.8B, net income $1.60B, EPS $1.20

CVS cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $10.6B, share buybacks $0, dividends $2.66 per share
• Fiscal year ended Dec 2024: operating cash flow $9.11B, share buybacks $3.02B, dividends $2.66 per share
• Fiscal year ended Dec 2023: operating cash flow $13.4B, share buybacks $2.01B, dividends $2.42 per share
• Fiscal year ended Dec 2022: operating cash flow $16.2B, share buybacks $3.50B, dividends $2.20 per share
• Fiscal year ended Dec 2021: operating cash flow $18.3B, share buybacks $0, dividends $2.00 per share

CVS balance sheet

• Jun 30, 2026: cash $11.3B, total assets $254B, total liabilities $174B, shareholders' equity $79.7B
• Mar 31, 2026: cash $9.54B, total assets $253B, total liabilities $175B, shareholders' equity $77.5B
• Dec 31, 2025: cash $8.45B, total assets $254B, total liabilities $178B, shareholders' equity $75.2B
• Sep 30, 2025: cash $9.10B, total assets $255B, total liabilities $182B, shareholders' equity $72.9B
• Jun 30, 2025: cash $11.8B, total assets $258B, total liabilities $181B, shareholders' equity $77.4B
• Mar 31, 2025: cash $10.1B, total assets $256B, total liabilities $178B, shareholders' equity $76.9B
• Dec 31, 2024: cash $8.59B, total assets $253B, total liabilities $177B, shareholders' equity $75.6B
• Sep 30, 2024: cash $6.88B, total assets $252B, total liabilities $177B, shareholders' equity $74.9B

What is CVS's revenue?

CVS HEALTH CORP reported $415B of revenue over its last four quarters, through June 30, 2026.

Is CVS profitable?

Yes. CVS HEALTH CORP earned $4.89B over the last four quarters.

What is CVS's EPS?

Diluted earnings per share over the last four quarters were $3.79; $2.31 in the latest quarter.

Does CVS pay a dividend?

CVS HEALTH CORP paid $2.66 per share in dividends in the fiscal year ended December 2025.

CVS ownership and insider trades · All stocks